Intravenous immunoglobulin-based immunotherapy: an arsenal of possibilities for patients and science (Q37773248)

22 August 2017

1 reference

title

Intravenous immunoglobulin-based immunotherapy: an arsenal of possibilities for patients and science (English)

1 reference

22 August 2017

1 reference

3

Francesco M Marincola

1 reference

22 August 2017

Beatrix Kotlan

1

1 reference

22 August 2017

David F Stroncek

series ordinal

2

1 reference

22 August 2017

language of work or name

1 reference

1 November 2009

1 reference

22 August 2017

1 reference

22 August 2017

volume

1

1 reference

22 August 2017

issue

6

1 reference

22 August 2017

page(s)

995-1015

1 reference

Translational Medicine: A two-way road

22 August 2017

cites work

1 reference

Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss

21 January 2018

1 reference

Facing the enigma of immunomodulatory effects of intravenous immunoglobulin

21 January 2018

1 reference

IVIg therapy in autoimmunity and related disorders: our experience with a large cohort of patients

21 January 2018

1 reference

Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study

21 January 2018

1 reference

Intravenous immunoglobulin treatment in multifocal motor neuropathy and other chronic immune-mediated neuropathies

21 January 2018

1 reference

The antiinflammatory activity of IgG: the intravenous IgG paradox

21 January 2018

1 reference

Update on treatment of immunologic abortion with low-dose intravenous immunoglobulin

21 January 2018

1 reference

Uncovering the hidden potential of intravenous immunoglobulin as an anticancer therapy

21 January 2018

1 reference

History of immunoglobulin replacement

21 January 2018

1 reference

What is the contents of the magic draft IVIg?

21 January 2018

1 reference

Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology

21 January 2018

1 reference

Novel approaches to therapy for systemic lupus erythematosus

21 January 2018

1 reference

Intravenous immunoglobulin therapy and systemic lupus erythematosus

21 January 2018

1 reference

Intravenous immunoglobulin: adverse effects and safe administration

21 January 2018

1 reference

Review: intravenous immunoglobulin therapy and thromboembolic complications

21 January 2018

1 reference

Safety of intravenous immunoglobulin (IVIG) therapy

21 January 2018

1 reference

Intravenous immunoglobulin in immunodeficiency states: state of the art.

21 January 2018

1 reference

Anti-idiotypes and their application under autoimmune, neoplastic, and infectious conditions

21 January 2018

1 reference

Intravenous immunoglobulin (IVIG): modes of action in the clinical management of recurrent pregnancy loss (RPL) and selected autoimmune disorders

21 January 2018

1 reference

Cancer immunotherapy: is there real progress at last?

21 January 2018

1 reference

Tumors as elusive targets of T-cell-based active immunotherapy

21 January 2018

1 reference

IVIG therapy: interfering with interferon-gamma

21 January 2018

1 reference

Long term safety of IVIg therapy in multiple sclerosis: 10 years experience

21 January 2018

1 reference

Immunomodulatory action of intravenous immunoglobulin.

21 January 2018

1 reference

Clinical uses of intravenous immunoglobulin.

21 January 2018

1 reference

High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood

21 January 2018

1 reference

The use of intravenous immune globulin in immunodeficiency diseases

21 January 2018

1 reference

Intravenous immunoglobulins for Alzheimer's disease

21 January 2018

1 reference

Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases

21 January 2018

1 reference

The therapeutic uses of intravenous immunoglobulins in autoimmune rheumatic diseases

21 January 2018

1 reference

IVIG rescue therapy in renal transplantation

21 January 2018

1 reference

Intravenous immunoglobulin and the kidney--a two-edged sword

21 January 2018

1 reference

Psoriasis: response to high-dose intravenous immunoglobulin in three patients.

21 January 2018

1 reference

Use of IGIV in the treatment of atopic dermatitis, urticaria, scleromyxedema, pyoderma gangrenosum, psoriasis, and pretibial myxedema.

21 January 2018

1 reference

Successful Intravenous Immunoglobulin Therapy in 3 Cases of Parvovirus B19–Associated Chronic Fatigue Syndrome

21 January 2018

1 reference

Intravenous Immunoglobulin is Ineffective in the Treatment of Patients with Chronic Fatigue Syndrome

21 January 2018

1 reference

Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura.

21 January 2018

1 reference

Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor

21 January 2018

1 reference

Reversible and irreversible loss of Fc receptor function of human monocytes as a consequence of interaction with immunoglobulin G.

21 January 2018

1 reference

Immunoglobulin for rheumatic diseases in the twenty-first century: take it or leave it?

21 January 2018

1 reference

Autoantibody level modification in adult patients with idiopathic thrombocytopenic purpura following intravenous immunoglobulin treatment

21 January 2018

1 reference

Increased blood plasma concentrations of TGF-beta isoforms after treatment with intravenous immunoglobulins (i.v.IG) in patients with multiple sclerosis

21 January 2018

1 reference

High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments

21 January 2018

1 reference

Advances in the understanding of the mechanism of action of IVIg

21 January 2018

1 reference

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

21 January 2018

1 reference

Interleukin-10 and the immune response against cancer: a counterpoint

21 January 2018

1 reference

Increased spontaneous apoptosis of CD4 CD25 T cells in patients with active rheumatoid arthritis is reduced by infliximab.

21 January 2018

1 reference

Intravenous immunoglobulin preparations and autoimmune disorders: mechanisms of action.

21 January 2018

1 reference

Intravenous gamma globulin inhibits the production of matrix metalloproteinase-9 in macrophages

21 January 2018

1 reference

An immunoglobulin agent (IVIG) inhibits NF-kappaB activation in cultured endothelial cells of coronary arteries in vitro

21 January 2018

1 reference

21 January 2018

The dual role of IL-10.

1 reference

The effects of intravenous immune globulin on complement-dependent immune damage of cells and tissues

21 January 2018

1 reference

Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients

21 January 2018

1 reference

New therapies for immune thrombocytopenic purpura

21 January 2018

1 reference

Novel mechanism for therapeutic action of IVIg in autoimmune blistering dermatoses

21 January 2018

1 reference

Serum anti-ganglioside IgM antibodies in soft tissue sarcoma: clinical prognostic implications

21 January 2018

1 reference

Vitiligo autoantibodies are effective against melanoma

21 January 2018

1 reference

Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin

21 January 2018

1 reference

Clinical and immune responses in resected colon cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen

21 January 2018

1 reference

Adjuvant immunotherapy for solid tumors: from promise to clinical application

21 January 2018

1 reference

IL-10 stimulatory effects on human NK cells explored by gene profile analysis

21 January 2018

1 reference

The immunologic constant of rejection

21 January 2018

1 reference

Tumour immunity: effector response to tumour and role of the microenvironment

21 January 2018

1 reference

Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy.

21 January 2018

1 reference

Immunotherapy of autoimmunity and cancer: the penalty for success

21 January 2018

1 reference

Monoclonal antibody-based genetic immunotherapy.

21 January 2018

1 reference

An anti-idiotype vaccine elicits a specific response to N-glycolyl sialic acid residues of glycoconjugates in melanoma patients

21 January 2018

1 reference

Active specific immunotherapy of metastatic melanoma with an antiidiotype vaccine: a phase I/II trial of I-Mel-2 plus SAF-m

21 January 2018

1 reference

Active specific immunotherapy in patients with melanoma. A clinical trial with mouse antiidiotypic monoclonal antibodies elicited with syngeneic anti-high-molecular-weight-melanoma-associated antigen monoclonal antibodies

21 January 2018

1 reference

Sequential immunization of melanoma patients with GD3 ganglioside vaccine and anti-idiotypic monoclonal antibody that mimics GD3 ganglioside

21 January 2018

1 reference

A phase II trial comparing five dose levels of BEC2 anti-idiotypic monoclonal antibody vaccine that mimics GD3 ganglioside

21 January 2018

1 reference

Ganglioside-based vaccines and anti-idiotype antibodies for active immunotherapy against cancer.

21 January 2018

1 reference

B cells in autoimmune diseases: insights from analyses of immunoglobulin variable (Ig V) gene usage

21 January 2018

1 reference

New take on comparative immunology: relevance to immunotherapy

21 January 2018

1 reference

Natural human immunoglobulins in cancer immunotherapy

21 January 2018

1 reference

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin

21 January 2018

1 reference

The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies

21 January 2018

1 reference

IVIG in autoimmunity and cancer--efficacy versus safety

21 January 2018

1 reference

Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia

21 January 2018

1 reference

Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use.

21 January 2018

1 reference

Human autoantibodies reactive with synthetic autoantigens from T-cell receptor beta chain

21 January 2018

1 reference

Naturally occurring IgM anti-leukocyte autoantibodies (IgM-ALA) inhibit T cell activation and chemotaxis

21 January 2018

1 reference

Naturally occurring B-cell responses to breast cancer

21 January 2018

1 reference

Death by stress: natural IgM-induced apoptosis

21 January 2018

1 reference

Anti-Tac (daclizumab, Zenapax) in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: a 25-year personal odyssey

21 January 2018

1 reference

Human neoplasms elicit multiple specific immune responses in the autologous host

21 January 2018

1 reference

Novel ganglioside antigen identified by B cells in human medullary breast carcinomas: the proof of principle concerning the tumor-infiltrating B lymphocytes

21 January 2018

1 reference

The microenvironment of germ cell tumors harbors a prominent antigen-driven humoral response

21 January 2018

1 reference

Invariance and restriction toward a limited set of self-antigens characterize neonatal IgM antibody repertoires and prevail in autoreactive repertoires of healthy adults

21 January 2018

1 reference

Anti-cytokine nature of natural human immunoglobulin: one possible mechanism of the clinical effect of intravenous immunoglobulin therapy

21 January 2018

1 reference

Augmentation of natural antiganglioside IgM antibodies in lower motor neuron disease (LMND) and role of CD5 B cells

21 January 2018

1 reference

Increased Levels of Galactose-Deficient Anti-Gal Immunoglobulin G in the Sera of Hepatitis C Virus-Infected Individuals with Fibrosis and Cirrhosis

21 January 2018

1 reference

Traveling for the glycosphingolipid path

21 January 2018

1 reference

Down-regulation of GD3 ganglioside and its O-acetylated derivative by stable transfection with antisense vector against GD3-synthase gene expression in hamster melanoma cells: effects on cellular growth, melanogenesis, and dendricity

21 January 2018

1 reference

Interferon-gamma reduces melanosomal antigen expression and recognition of melanoma cells by cytotoxic T cells

21 January 2018

1 reference

Glycoimmunomics of human cancer: current concepts and future perspectives

21 January 2018

1 reference

A new tumor-specific variant of GRP78 as target for antibody-based therapy

21 January 2018

1 reference

Acetylation suppresses the proapoptotic activity of GD3 ganglioside.

21 January 2018

1 reference

By-passing immunization. Human antibodies from V-gene libraries displayed on phage

21 January 2018

1 reference

Restricted VH3 gene usage in phage-displayed Fab that are selected by intravenous immunoglobulin

21 January 2018

1 reference

IVIG-bound IgG and IgM cloned by phage display from a healthy individual reveal the same restricted germ-line gene origin as in autoimmune thrombocytopenia

21 January 2018

1 reference

Structure, function and properties of antibody binding sites

21 January 2018

1 reference

Isolation and characterization of phage-displayed single chain antibodies recognizing nonreducing terminal mannose residues. 2. Expression, purification, and characterization of recombinant single chain antibodies

21 January 2018

1 reference

Tumor-infiltrating B cell immunoglobulin variable region gene usage in invasive ductal breast carcinoma

21 January 2018

1 reference

Focused antibody response in plasma cell-infiltrated non-medullary (NOS) breast cancers.

21 January 2018

1 reference

Natural autoantibodies reactive with glycosaminoglycans in rheumatoid arthritis.

21 January 2018

1 reference

Carbohydrate recognition systems in autoimmunity.

21 January 2018

1 reference

Toward molecular targeting with specific intravenous immunoglobulin preparation

21 January 2018

1 reference

Is intravenous immunoglobulins (IVIG) efficacious in early pregnancy failure? A critical review and meta-analysis for patients who fail in vitro fertilization and embryo transfer (IVF).

21 January 2018

1 reference

Immunological factors in pregnancy wastage: fact or fiction

21 January 2018

1 reference

Is there any evidence for immunologically mediated or immunologically modifiable early pregnancy failure?

21 January 2018

1 reference

Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systematic review.

21 January 2018

1 reference

Successful treatment of immunologic abortion with low-dose intravenous immunoglobulin

21 January 2018

1 reference

Immunotherapy for recurrent pregnancy loss: analysis of results from clinical trials

21 January 2018

1 reference

Intravenous immunoglobulin in the prevention of recurrent spontaneous abortion: the European experience

21 January 2018

1 reference

Intravenous immunoglobulin therapy of antiphospholipid syndrome

21 January 2018

1 reference

A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation

21 January 2018

1 reference

Immunoglobulin variable regions usage by B-lymphocytes infiltrating a human breast medullary carcinoma

21 January 2018

1 reference

Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation

21 January 2018

1 reference

Autoantibodies Against Ganglioside GM3 Represent a Portion of Anti-Lymphocyte Antibodies in AIDS Patients

21 January 2018

1 reference

Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/IMT.09.67

1 reference

22 August 2017

1 reference